Niagen Bioscience (NAGE) Other Non Operating Income (2016 - 2018)
Niagen Bioscience (NAGE) reported Other Non Operating Income of -$65000.0 for Q2 2018, up 79.24% quarter-over-quarter from -$313099.0 in Q3 2016.
Niagen Bioscience (NAGE) Other Non Operating Income (2016 - 2018) Analysis & Trends
Niagen Bioscience (NAGE) has 2 years of Other Non Operating Income data on file, last reported at -$65000.0 in Q2 2018.
- Other Non Operating Income for Q2 2018 came in at -$65000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was -$65000.0 (changed N/A YoY), and the FY2018 annual result was -$65000.0, changed N/A from the prior year.
- Other Non Operating Income rose to -$65000.0 in Q2 2018 per NAGE's latest filing, from -$313099.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at -$65000.0 in Q2 2018 and troughed at -$313099.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -65,000.00 |
| Jul 2, 2016 | -313,099.00 |